0
Facebook
Volume 84 Issue 15 | pp. 19-27
Issue Date: April 10, 2006

Cover Stories

Pharma Outsourcing

The search for a cure for cancer unites three partnerships between a drug developer and a pharmaceutical chemical company
Department: Business
[+]Enlarge
Reflections
Chemist Annette Shaw works up a reaction in Scynexis' Research Triangle Park laboratories.
Credit: Scynexis Photo
8415cover1_open
 
Reflections
Chemist Annette Shaw works up a reaction in Scynexis' Research Triangle Park laboratories.
Credit: Scynexis Photo

The advertisements in popular magazines would convince most readers that the pharmaceutical industry is ruled by giant multinational companies focused exclusively on "lifestyle" drugs to fix problems that could be cured through more healthful living.

In fact, much pharmaceutical research is conducted by small companies that many magazine readers have never heard of. And many of the industry's research dollars are spent confronting serious afflictions such as cancer, heart disease, pain, and infection. For example, in the U.S. last year there were 399 drugs in development to treat cancer and 146 for heart disease and stroke, according to Pharmaceutical Research & Manufacturers of America.

Two of the drugs are still in development, and if history is any guide, one or both of them will fail for one reason or another. Drug development is a high-risk business, but the stories of the scientists who discover and synthesize such compounds are always compelling.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society